CWM
CYTK icon

Centricity Wealth Management’s Cytokinetics CYTK Stock Holding History

Centricity Wealth Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$20.6K Hold
624
– – 0.02% 252
2025
Q1 		$25.1K Hold
624
– – 0.02% 232
2024
Q4 		$29.4K Buy
+624
New +$32.4K 0.03% 217

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Centricity Wealth Management's CYTK Position: Q2 2025 in Review

Centricity Wealth Management held its Cytokinetics (CYTK) position steady in Q2 2025 at 624 shares worth $20.6K. The position accounts for 0.02% of the portfolio, ranked #252.

Centricity Wealth Management first reported a position in CYTK in Q4 2024 and has held it in 3 quarters since. The position peaked at $29.4K in Q4 2024. 311 funds tracked by Wall St. Rank hold CYTK as of Q2 2025.

  • Centricity Wealth Management held 624 shares of Cytokinetics worth $20.6K as of Q2 2025.
  • Centricity Wealth Management left its Cytokinetics share count unchanged in Q2 2025.
  • Cytokinetics made up 0.02% of Centricity Wealth Management's portfolio in Q2 2025, its #252 holding.
  • Centricity Wealth Management first reported a position in Cytokinetics in Q4 2024 and has held it in 3 quarters since.
  • Centricity Wealth Management's Cytokinetics position peaked at $29.4K in Q4 2024.
  • 311 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.